Comparative efficacy and safety of subcutaneous infliximab and vedolizumab maintenance therapy in patients with crohn’s disease and ulcerative colitis: an indirect comparison from randomized controlled trials

Gastroenterology(2024)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要